Wildwood, MO, United States of America

Brian S Hickory


Average Co-Inventor Count = 17.3

ph-index = 9

Forward Citations = 304(Granted Patents)


Location History:

  • Wildwood, MI (US) (2004)
  • Wildwood, MO (US) (2002 - 2010)

Company Filing History:


Years Active: 2002-2010

Loading Chart...
41 patents (USPTO):

Title: Brian S Hickory: Innovator in Pharmaceutical Chemistry

Introduction

Brian S Hickory, based in Wildwood, MO, is a notable inventor with an impressive portfolio of 41 patents. His contributions to the field of pharmaceutical chemistry, particularly in the development of compound therapies, have significantly advanced the understanding and treatment of various diseases.

Latest Patents

Among his latest innovations is the patent for (R)-chiral halogenated substituted fused heterocyclic amino compounds useful for inhibiting cholesterol ester transfer protein activity. This invention involves a class of compounds that serve as inhibitors of cholesteryl ester transfer protein (CETP), which is crucial in regulating plasma lipid levels. The patented processes describe novel high-yield, stereoselective methods for synthesizing these chiral substituted alkanol compounds from both chiral and achiral intermediates. Another key patent includes diaryl substituted pyridinones, which presents valuable chemical compositions and applications.

Career Highlights

Throughout his career, Brian has worked with major pharmaceutical companies, including Pharmacia Corporation and G.D. Searle & Company. His professional journey highlights his dedication to research and innovation in chemistry and its applications.

Collaborations

Brian has collaborated with talented professionals in the field, including Richard C Durley and Michele A Promo. Their joint efforts in research exemplify the importance of teamwork in driving scientific advancements and breaking new ground in medicine.

Conclusion

Brian S Hickory is an accomplished inventor whose work continues to impact pharmaceutical science significantly. His innovative patents and collaborations with peers have contributed to the advancement of treatments for conditions like atherosclerosis and coronary artery diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…